About Us
Kytel Therapeutics is an India-based pharmaceutical company specializing in the development, registration, and supply of high-quality finished formulations from WHO-GMP certified manufacturers to pharma companies, importers, and distributors across Africa.
Kytel operates on a demand-led, partnership-driven model. We work closely with local distributors to identify portfolio gaps and market requirements, then evaluate, develop, and register suitable products under the Kytel brand for long-term commercialization in their markets.
To shape the future of global healthcare through innovation, scientific excellence and trusted partnerships, making advanced healthcare solutions more accessible and affordable for communities worldwide.
To bridge global healthcare needs by sourcing, supplying and delivering high-quality healthcare products that improve access, enhance affordability and create lasting value for patients, partners and communities.
Narrow focus, uncompromising quality.
Operating out of the world's largest generic-producing nation
Partnering with distributors across product selection, registration and long-term market development
Built to widen access to chronic care worldwide under the Kytel brand
Cardiovascular, Anti-Diabetic, CNS and Respiratory, supported by essential Anti‑Infectives and Analgesics
Asset light. Quality first.
Every shipment is backed by comprehensive quality documentation — CoA, CoPP, MSDS, Free Sale Certificate, batch certificates and ICH Zone IVb stability data where applicable.
Partner facilities operate controlled cleanroom environments, ensuring pharmaceutical-grade consistency across all product categories.
A broad manufacturer network across therapeutic areas enables flexible sourcing by product, volume, and specification.